Literature DB >> 26908289

A cross-sectional study of functional disabilities and perceived cognitive dysfunction in patients with major depressive disorder in South Korea: The PERFORM-K study.

Jae Min Kim1, Ylana Chalem2, Sylvia di Nicola2, Jin Pyo Hong3, Seung Hee Won4, Dominique Milea5.   

Abstract

PERFORM-K was a cross-sectional observational study that investigated functional disability, productivity and quality of life in MDD outpatients in South Korea, and the associations of these with depressive symptoms, perceived cognitive dysfunction and other factors. A total of 312 outpatients who started antidepressant monotherapy underwent a single study interview. Physicians and patients assessed depression severity. Patients also assessed: perceived cognitive dysfunction, functional disability, impaired productivity and quality of life. Patients had moderate to severe depression (MADRS mean total score: 28.9±7.3), and reported marked functional disability (SDS mean total score: 16.7±8.6), impaired productivity (WPAI mean overall work productivity loss: 52.4±31.8%), perceived cognitive dysfunction (PDQ-D mean total score: 29.9±18.6) and impaired quality of life (EQ-5D mean utility index score of 0.726±0.192). Greater functional disability and impairment in daily activities were associated with more severe depression and greater perceived cognitive dysfunction. Irrespective of depression severity, patients with more severe perceived cognitive dysfunction reported worse work-related productivity outcomes (higher presenteeism and greater overall work productivity loss). PERFORM-K confirms the impact of MDD on functional status and well-being in South Korean patients, and highlights the importance of recognising cognitive dysfunction in clinical practice.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Absenteeism; Cognition; Depression; Functioning; Presenteeism; Work productivity

Mesh:

Year:  2016        PMID: 26908289     DOI: 10.1016/j.psychres.2016.01.022

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Depression, health comorbidities, cognitive symptoms and their functional impact: Not just a geriatric problem.

Authors:  Sophia Miryam Schüssler-Fiorenza Rose; Nicholas T Bott; Erin E Heinemeyer; Nathan C Hantke; Christine E Gould; Rayna B Hirst; Joshua T Jordan; Sherry A Beaudreau; Ruth O'Hara
Journal:  J Psychiatr Res       Date:  2021-05-07       Impact factor: 5.250

2.  Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study.

Authors:  Srisurapanont Manit; Mok Yee Ming; Yang Yen Kuang; Chan Herng-Nieng; Della Constantine D; Zainal Nor Zuraida; Jambunathan Stephen; Amir Nurmiati; Kalita Pranabi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-10-31

3.  Discrepancy between objective and subjective cognition in adults with major depressive disorder.

Authors:  Manit Srisurapanont; Sirijit Suttajit; Kanokkwan Eurviriyanukul; Prirada Varnado
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

4.  Functional impairment among people diagnosed with depression in primary healthcare in rural Ethiopia: a comparative cross-sectional study.

Authors:  Kassahun Habtamu; Girmay Medhin; Medhin Selamu; Kebede Tirfessa; Charlotte Hanlon; Abebaw Fekadu
Journal:  Int J Ment Health Syst       Date:  2019-07-17

5.  Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study.

Authors:  Tomiki Sumiyoshi; Koichiro Watanabe; Shinichi Noto; Shigeru Sakamoto; Yoshiya Moriguchi; Shuichi Okamoto
Journal:  JMIR Res Protoc       Date:  2018-06-25

6.  Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study.

Authors:  Josep Maria Haro; Lene Hammer-Helmich; Delphine Saragoussi; Anders Ettrup; Klaus Groes Larsen
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-13       Impact factor: 2.570

7.  Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD).

Authors:  Pratap Chokka; Joanna Bougie; Emmanouil Rampakakis; Jean Proulx
Journal:  CNS Spectr       Date:  2018-05-24       Impact factor: 3.790

8.  Functional impairment in patients with major depressive disorder: the 2-year PERFORM study.

Authors:  Lene Hammer-Helmich; Josep Maria Haro; Bengt Jönsson; Audrey Tanguy Melac; Sylvie Di Nicola; Julien Chollet; Dominique Milea; Benoît Rive; Delphine Saragoussi
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-09       Impact factor: 2.570

9.  Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study.

Authors:  Delphine Saragoussi; Michael Cronquist Christensen; Lene Hammer-Helmich; Benoît Rive; Maëlys Touya; Josep Maria Haro
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-22       Impact factor: 2.570

10.  Associations between the depressive symptoms, subjective cognitive function, and presenteeism of Japanese adult workers: a cross-sectional survey study.

Authors:  Kuniyoshi Toyoshima; Takeshi Inoue; Akiyoshi Shimura; Jiro Masuya; Masahiko Ichiki; Yota Fujimura; Ichiro Kusumi
Journal:  Biopsychosoc Med       Date:  2020-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.